Omjjara
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Omjjara, covering 2025-05-12 to 2026-06-08. Get the full timeline:
Most recent: EMA Authorised: Omjjara (Momelotinib dihydrochloride monohydrate) — GlaxoSmithKline Trading Services Limited